What is the recommended dose of benzathine penicillin G (Bicillin) for the treatment of syphilis, administered one dose every week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzathine Penicillin G Dosing for Syphilis

For early syphilis (primary, secondary, or early latent), administer benzathine penicillin G 2.4 million units IM as a single dose; for late latent syphilis or syphilis of unknown duration, administer 2.4 million units IM weekly for three consecutive weeks (total 7.2 million units). 1, 2

Dosing by Syphilis Stage

Early Syphilis (Primary, Secondary, or Early Latent)

  • Single dose of 2.4 million units IM is the standard treatment for adults 1, 2
  • This applies to patients with documented infection acquired within the preceding year 1
  • The most recent high-quality randomized trial (2025) confirmed that one dose is noninferior to three doses, with 76% serologic response at 6 months in both HIV-infected and HIV-uninfected patients 3

Late Latent Syphilis or Unknown Duration

  • Three doses of 2.4 million units IM administered at 1-week intervals (total 7.2 million units) 1, 2
  • Each injection must be spaced exactly 7 days apart 2
  • If a dose is missed, pharmacologic considerations suggest a 10-14 day interval may be acceptable before restarting the sequence, though this should not be considered acceptable for pregnant patients 1, 2

Special Population Considerations

HIV-Infected Patients

  • Use the same single-dose regimen for early syphilis as HIV-uninfected patients 2, 4, 3
  • A 2017 randomized trial found no benefit to three doses versus one dose in HIV-infected patients with early syphilis (80% vs 93% success rates, not statistically significant) 4
  • The 2025 NEJM trial definitively established noninferiority of single-dose therapy regardless of HIV status 3
  • While one older observational study from 2014 suggested higher failure rates with single-dose therapy in HIV-infected patients 5, the more recent and higher-quality randomized controlled trials 4, 3 support single-dose treatment

Pediatric Dosing

  • 50,000 units/kg IM (up to adult dose of 2.4 million units) as a single dose for early latent syphilis 1, 2
  • For late latent syphilis: 50,000 units/kg IM administered as three doses at 1-week intervals (total 150,000 units/kg, up to adult total of 7.2 million units) 1, 2
  • All children require CSF examination to exclude neurosyphilis before treatment 1, 2

Pregnant Patients

  • Use the same stage-appropriate penicillin dosing as non-pregnant adults 2, 6
  • Penicillin is the only proven effective treatment to prevent mother-to-fetal transmission 2
  • Pregnant women who miss any dose during three-dose therapy must repeat the full course 1
  • Penicillin-allergic pregnant women must be desensitized, as alternatives like doxycycline and tetracyclines do not prevent congenital syphilis 2, 6

Critical Clinical Pitfalls

Staging Accuracy

  • Patients must meet specific criteria to be classified as early latent syphilis: documented seroconversion within the past year, unequivocal symptoms of primary/secondary syphilis within the past year, or a sex partner with documented early syphilis 1
  • When in doubt, treat as late latent syphilis (three doses) rather than risk undertreatment 1
  • Nontreponemal titers alone cannot reliably distinguish early from late latent syphilis 1

Neurosyphilis Exclusion

  • Perform CSF examination before treating with standard benzathine penicillin regimens if patients have: neurologic/ophthalmic symptoms, evidence of tertiary syphilis, treatment failure, or HIV infection with late latent syphilis 1
  • If neurosyphilis is confirmed, benzathine penicillin is inadequate; use aqueous crystalline penicillin G 18-24 million units/day IV for 10-14 days instead 6, 7

Follow-Up and Treatment Response

  • Monitor quantitative nontreponemal tests (RPR/VDRL) at 6,12, and 24 months 1
  • Expect a fourfold (two-dilution) decline in titer within 6 months for primary/secondary syphilis 2, 6
  • Treatment failure is defined as: titers increasing fourfold after initial decline, or initially high titer (≥1:32) failing to decline fourfold within 12-24 months 1, 2

HIV Testing

  • All patients with syphilis should be tested for HIV infection 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benzathine Penicillin Dosing for Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.